Novartis India plans rights issue
Novartis India (BSE: NOVARTIND) said it has taken up rights issue. The company is valued at about ₹3,754 crore.
What happened
Novartis India (BSE: NOVARTIND) informed the stock exchanges on 16 November 2026 at 03:21 PM that it has taken up rights issue.
From the filing: "Newspaper Publication w.r.t. the dispatch of Letter of Offer and issue materials for the Rights Issue of the Equity Shares of the Company."
Company snapshot
Novartis India is a small-cap company, with a market value of about ₹3,754 crore.
The stock last traded at ₹1,520.4, against a 52-week range of ₹672.3–₹2,391.3 (36.4% below the high).
Before this filing the shares had moved −9.1% over the month and +13.7% over three months. Average daily turnover over the last 20 sessions was about ₹7.37 crore.
Promoters held 70.68% at the end of Q2 FY27. Foreign institutions owned 1.22% and domestic institutions 1.50%.
| Quarter | Revenue | Net profit | EPS (₹) |
|---|---|---|---|
| Q2 FY26 | 90 | 24.2 | 9.81 |
| Q3 FY26 | 86 | 16.1 | 6.52 |
| Q4 FY26 | 91 | 25.3 | 10.23 |
| Q1 FY27 | 104 | 32.2 | 13.05 |
| Q2 FY27 | 56 | -77.5 | -31.41 |
What history shows
BCEIE's records show 5 previous fund raising filings from the company since May 2026.
After those filings, the stock gained 2.7% on average the next trading day (5 filings with price data).
Market-wide, 1,814 fund raising filings with an impact score of 50 or more saw an average next-day move of +0.3%, with 48% rising.
Past reactions describe what happened before; they are not a forecast.
| Date | Filing | Next day | 5 days |
|---|---|---|---|
| 5 Nov 2026 | Submission of the Letter of Offer in connection with the proposed… | +6.0% | — |
| 4 Nov 2026 | Intimation is hereby given that the record date for determining the… | +2.6% | — |
| 4 Nov 2026 | Outcome of the meeting of the Rights Issue Committee held today i.e.… | +2.6% | — |
| 8 Oct 2026 | The Board of Directors of the Company Evonile Pharma Limited… | +1.3% | — |
| 8 Oct 2026 | The Board of Directors of Evonile Pharma Limited (formally known as… | +1.3% | — |
What to watch
- How the money raised is used and, for equity instruments, the dilution for existing shareholders.
In the news
Recent coverage elsewhere (links open the original publisher):
Source
Automatically written from the exchange filing and BCEIE data. Not investment advice. Check the original filing before acting on it.